Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 245

1.

Effect of prophylactically applied CpG ODN on the development of myocarditis in mice infected with Coxsackievirus B3.

Zhao T, Wu X, Song D, Fang M, Guo S, Zhang P, Wang L, Wang L, Yu Y.

Int Immunopharmacol. 2012 Dec;14(4):665-73. doi: 10.1016/j.intimp.2012.09.018. Epub 2012 Oct 9.

PMID:
23063973
2.

[Effect of a C-type CpG ODN on CVB3-infected mice].

Yang L, Sun WQ, Wang L, Wang XL, Wan M, Yu YL, Wang LY.

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2009 Feb;25(2):115-7. Chinese.

PMID:
19174007
3.

α-Galactosylceramide protects mice from lethal Coxsackievirus B3 infection and subsequent myocarditis.

Wu CY, Feng Y, Qian GC, Wu JH, Luo J, Wang Y, Chen GJ, Guo XK, Wang ZJ.

Clin Exp Immunol. 2010 Oct;162(1):178-87. doi: 10.1111/j.1365-2249.2010.04233.x. Epub 2010 Aug 19.

4.

Coxsackievirus B3-induced chronic myocarditis in mouse: use of whole blood culture to study the activation of TNF alpha-producing cells.

Hober D, Andreoletti L, Shen L, Copin MC, Desmidt A, Wattré P.

Microbiol Immunol. 1996;40(11):837-45.

5.

The viral genetic background determines the outcome of coxsackievirus B3 infection in outbred NMRI mice.

Schmidtke M, Merkle I, Klingel K, Hammerschmidt E, Zautner AE, Wutzler P.

J Med Virol. 2007 Sep;79(9):1334-42.

PMID:
17607777
6.

Protease-activated receptor-2 regulates the innate immune response to viral infection in a coxsackievirus B3-induced myocarditis.

Weithauser A, Bobbert P, Antoniak S, Böhm A, Rauch BH, Klingel K, Savvatis K, Kroemer HK, Tschope C, Stroux A, Zeichhardt H, Poller W, Mackman N, Schultheiss HP, Rauch U.

J Am Coll Cardiol. 2013 Nov 5;62(19):1737-45. doi: 10.1016/j.jacc.2013.05.076. Epub 2013 Jul 17.

7.

CXCL10 inhibits viral replication through recruitment of natural killer cells in coxsackievirus B3-induced myocarditis.

Yuan J, Liu Z, Lim T, Zhang H, He J, Walker E, Shier C, Wang Y, Su Y, Sall A, McManus B, Yang D.

Circ Res. 2009 Mar 13;104(5):628-38. doi: 10.1161/CIRCRESAHA.108.192179. Epub 2009 Jan 22.

8.

Persistence of replicating coxsackievirus B3 in the athymic murine heart is associated with development of myocarditic lesions.

Sato S, Tsutsumi R, Burke A, Carlson G, Porro V, Seko Y, Okumura K, Kawana R, Virmani R.

J Gen Virol. 1994 Nov;75 ( Pt 11):2911-24.

PMID:
7964602
9.

The comparison of α-bromo-4-chlorocinnamaldehyde and cinnamaldehyde on coxsackie virus B3-induced myocarditis and their mechanisms.

Zhang Y, Cao W, Xie YH, Yang Q, Li XQ, Liu XX, Wang SW.

Int Immunopharmacol. 2012 Sep;14(1):107-13. doi: 10.1016/j.intimp.2012.06.007. Epub 2012 Jun 15.

PMID:
22709476
10.
11.

Pathogenesis of coxsackievirus B3-induced myocarditis: role of macrophage migration inhibitory factor.

Yu XH, Li SJ, Chen RZ, Yang YZ, Zhang P.

Chin Med J (Engl). 2012 Jan;125(1):50-5.

PMID:
22340465
12.

Treatment of coxsackievirus-B3-infected BALB/c mice with the soluble coxsackie adenovirus receptor CAR4/7 aggravates cardiac injury.

Dörner A, Grunert HP, Lindig V, Chandrasekharan K, Fechner H, Knowlton KU, Isik A, Pauschinger M, Zeichhardt H, Schultheiss HP.

J Mol Med (Berl). 2006 Oct;84(10):842-51. Epub 2006 Aug 5.

PMID:
16924471
13.

Vaccination with coxsackievirus B3 virus-like particles elicits humoral immune response and protects mice against myocarditis.

Zhang L, Parham NJ, Zhang F, Aasa-Chapman M, Gould EA, Zhang H.

Vaccine. 2012 Mar 16;30(13):2301-8. doi: 10.1016/j.vaccine.2012.01.061. Epub 2012 Jan 31.

PMID:
22306858
14.

Coxsackievirus B3-induced chronic myocarditis in outbred NMRI mice.

Merkle I, Tonew M, Glück B, Schmidtke M, Egerer R, Stelzner A.

J Hum Virol. 1999 Nov-Dec;2(6):369-79.

PMID:
10774554
15.

The heart-protective mechanism of Qishaowuwei formula on murine viral myocarditis induced by CVB3.

Fengqin L, Yulin W, Xiaoxin Z, Youpeng J, Yan C, Qing-qing W, Hong C, Jia S, Lei H.

J Ethnopharmacol. 2010 Feb 3;127(2):221-8. doi: 10.1016/j.jep.2009.11.017. Epub 2009 Nov 20.

PMID:
19932162
16.

Inhibition of Histone Deacetylase Activity Aggravates Coxsackievirus B3-Induced Myocarditis by Promoting Viral Replication and Myocardial Apoptosis.

Zhou L, He X, Gao B, Xiong S.

J Virol. 2015 Oct;89(20):10512-23. doi: 10.1128/JVI.01028-15. Epub 2015 Aug 12.

17.

[Protective effect and mechanism of IL-17 monoclonal antibody on mice with viral myocarditis].

Qian H, Liu L.

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2014 May;30(5):509-12. Chinese.

PMID:
24796747
18.

Viral myocarditis: identification of five differentially expressed genes in coxsackievirus B3-infected mouse heart.

Yang D, Yu J, Luo Z, Carthy CM, Wilson JE, Liu Z, McManus BM.

Circ Res. 1999 Apr 2;84(6):704-12.

19.

QiHong prevents death in coxsackievirus B3 induced murine myocarditis through inhibition of virus attachment and penetration.

Song X, Liu Z, Wang H, Xin Y, Wang X, Chen J, Shi Y, Zhang C, Hui R.

Exp Biol Med (Maywood). 2007 Dec;232(11):1441-8.

PMID:
18040068
20.

Distinct Th17 inductions contribute to the gender bias in CVB3-induced myocarditis.

Li Z, Yue Y, Xiong S.

Cardiovasc Pathol. 2013 Sep-Oct;22(5):373-82. doi: 10.1016/j.carpath.2013.02.004. Epub 2013 Mar 20.

PMID:
23523188

Supplemental Content

Support Center